Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

The Novel Small Molecule Chk1/Chk2 Inhibitor PF-0477736 (Pfizer) Is Highly Active As Single Agent in Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Blood (2011) 118 (21): 76.

https://doi.org/10.1182/blood.V118.21.76.76

Published: 2011

Journal Articles

PGE 2 -Independent Expression of Indoleamine 2,3-Dioxygenase-2 (IDO2) Supports the Tolerogenic Function of Monocyte-Derived Dendritic Cells,

Sara Trabanelli, Antonio Curti, MD, Darina Ocadlikova, Cecilia Evangelisti, Valentina Salvestrini, Marilena Ciciarello, Michela Aluigi, PhD, Lara Rossi, Richard Metz, Lisa Laury-Kleintop, George Prendergast, Roberto M. Lemoli, MD

Blood (2011) 118 (21): 3231.

https://doi.org/10.1182/blood.V118.21.3231.3231

Published: 2011

Journal Articles

HIF 1 Alpha: A Suitable Target for Multiple Myeloma

Giulia Perrone, MD, Enrica Borsi, PhD, Carolina Terragna, PhD, Sandra Durante, Marina Martello, Michela Aluigi, PhD, Manuela Mancini, PhD, Elena Zamagni, MD, Paola Tacchetti, MD, Annamaria Brioli, MD, Lucia Pantani, MD, Beatrice Anna Zannetti, MD, Giovanni Martinelli, MD, Maria Alessandra Santucci, MD, Michele Baccarani, MD, Michele Cavo, MD

Blood (2011) 118 (21): 2901.

https://doi.org/10.1182/blood.V118.21.2901.2901

Published: 2011

Journal Articles

C22 orf2 Gene (22q13.1) Translocation Downstream of Bcr Breakpoint (22q11) to the Derivative 9 Chromosome Is Associated with Reduced Expression of Its Protein, the Beta-Catenin Antagonist Chibby, in Chronic Myeloid Leukemia Progenitors

Michela Aluigi, PhD, Manuela Mancini, PhD, Elisa Leo, PhD, Fausto Castagnetti, Carmen Baldazzi, Enza Barbieri, MD, Maria Alessandra Santucci, MD

Blood (2011) 118 (21): 1676.

https://doi.org/10.1182/blood.V118.21.1676.1676

Published: 2011

Journal Articles

Modulation of Tryptophan Catabolism by Acute Myeloid Leukemia Cells Acts as a General Mechanism of Immune Tolerance Via the Induction of T Regulatory Cells.

Antonio Curti, MD, Valentina Salvestrini, BS, Michela Aluigi, PhD, Sara Trabanelli, BS, Emanuela Ottaviani, BS, Ilaria Durelli, BS, Alberto L. Horenstein, MD, Francesca Fiore, MD, Massimo Massaia, MD, Milena Piccioli, BS, Stefano Pileri, MD, Giovanni Martinelli, MD, Michele Baccarani, MD, Roberto M. Lemoli, MD

Blood (2007) 110 (11): 1345.

https://doi.org/10.1182/blood.V110.11.1345.1345

Published: 2007

Journal Articles

Quantitative Molecular Expression of the Immunoregulatory Enzyme Indoleamine 2,3-Dioxygenase in Acute Myeloid Leukemia Cells as a Possible Marker for Minimal Residual Disease Detection.

Michela Aluigi, PhD, Antonio Curti, MD, Emanuela Ottaviani, PhD, Giovanna Lucchetti, BS, Valentina Salvestrini, BS, Alessandra D’Addio, MD, Sara Trabanelli, BS, Francesca Fiore, MD, Massimo Massaia, MD, Giovanni Martinelli, MD, Michele Baccarani, MD, Roberto M. Lemoli, MD

Blood (2007) 110 (11): 4229.

https://doi.org/10.1182/blood.V110.11.4229.4229

Published: 2007

Journal Articles

Acute Myeloid Leukemia-Derived Dendritic Cells Express the Immunoregulatory Enzyme Indoleamine 2,3-dioxygenase.

Antonio Curti, MD, Simona Pandolfi, BS, Michela Aluigi, Phd, Elisa Ferri, Phd, Emanuela Ottaviani, BS, Ilaria Durelli, BS, Alberto L. Horenstein, MD, Francesca Fiore, MD, Massimo Massaia, MD, Milena Piccioli, BS, Stefano A. Pileri, MD, Giovanni Martinelli, MD, Michele Baccarani, MD, Roberto M. Lemoli, MD

Blood (2006) 108 (11): 1899.

https://doi.org/10.1182/blood.V108.11.1899.1899

Published: 2006

NARROW

The Novel Small Molecule Chk1/Chk2 Inhibitor PF-0477736 (Pfizer) Is Highly Active As Single Agent in Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

PGE 2 -Independent Expression of Indoleamine 2,3-Dioxygenase-2 (IDO2) Supports the Tolerogenic Function of Monocyte-Derived Dendritic Cells,

HIF 1 Alpha: A Suitable Target for Multiple Myeloma

C22 orf2 Gene (22q13.1) Translocation Downstream of Bcr Breakpoint (22q11) to the Derivative 9 Chromosome Is Associated with Reduced Expression of Its Protein, the Beta-Catenin Antagonist Chibby, in Chronic Myeloid Leukemia Progenitors

Modulation of Tryptophan Catabolism by Acute Myeloid Leukemia Cells Acts as a General Mechanism of Immune Tolerance Via the Induction of T Regulatory Cells.

Quantitative Molecular Expression of the Immunoregulatory Enzyme Indoleamine 2,3-Dioxygenase in Acute Myeloid Leukemia Cells as a Possible Marker for Minimal Residual Disease Detection.

Acute Myeloid Leukemia-Derived Dendritic Cells Express the Immunoregulatory Enzyme Indoleamine 2,3-dioxygenase.

Email alerts

ASH Publications

American Society of Hematology

The Novel Small Molecule Chk1/Chk2 Inhibitor PF-0477736 (Pfizer) Is Highly Active As Single Agent in Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

PGE 2 -Independent Expression of Indoleamine 2,3-Dioxygenase-2 (IDO2) Supports the Tolerogenic Function of Monocyte-Derived Dendritic Cells,

HIF 1 Alpha: A Suitable Target for Multiple Myeloma

C22 orf2 Gene (22q13.1) Translocation Downstream of Bcr Breakpoint (22q11) to the Derivative 9 Chromosome Is Associated with Reduced Expression of Its Protein, the Beta-Catenin Antagonist Chibby, in Chronic Myeloid Leukemia Progenitors

Modulation of Tryptophan Catabolism by Acute Myeloid Leukemia Cells Acts as a General Mechanism of Immune Tolerance Via the Induction of T Regulatory Cells.

Quantitative Molecular Expression of the Immunoregulatory Enzyme Indoleamine 2,3-Dioxygenase in Acute Myeloid Leukemia Cells as a Possible Marker for Minimal Residual Disease Detection.

Acute Myeloid Leukemia-Derived Dendritic Cells Express the Immunoregulatory Enzyme Indoleamine 2,3-dioxygenase.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only